Research Article
Evaluation of Clinical and Immunological Characteristics of Children with Common Variable Immunodeficiency
| | P | CD19 (%) | Range (%) | CD3 (%) | Range (%) | CD4 (%) | Range (%) | CD4/µL | CD8 (%) | Range (%) | CD4/CD8 |
| | 1 | 12 (N) | (10–30) | 69 (N) | (58–82) | 42 (N) | (26–48) | 478 | 29 (N) | (16–32) | 1.4 | | 2 | 5 (L) | (10–27) | 83 (N) | (57–81) | 37 (N) | (24–47) | 925 | 41 (N) | (17–37) | 0.9 | | 3 | 8 (L) | (10–30) | 72 (N) | (58–82) | 41 (N) | (26–48) | 1328 | 31 (N) | (16–32) | 1.3 | | 4 | 6 (L) | (11–31) | 85 (N) | (55–79) | 43 (N) | (26–49) | 774 | 36 (N) | (9–35) | 1.1 | | 5 | 8 (L) | (10–27) | 90 (N) | (57–81) | 11 (L) | (24–47) | 1386 | 75 (H) | (17–37) | 0.1 | | 6 | 7 (L) | (10–30) | 89 (N) | (58–82) | 21 (L) | (26–48) | 336 | 54 (H) | (17–37) | 0.38 | | 7 | 6 (L) | (10–30) | 82 (N) | (58–82) | 27 (N) | (26–48) | 270 | 45 (H) | (17–37) | 0.6 | | 8 | 9 (L) | (10–30) | 70 (N) | (58–82) | 33 (L) | (26–48) | 560 | 36 (N) | (17–37) | 0.9 | | 9 | 12 (N) | (10–30) | 90 (N) | (58–82) | 30 (N) | (26–48) | 420 | 37 (N) | (17–37) | 0.8 | | 10 | 10 (N) | (10–30) | 76 (N) | (58–82) | 30 (N) | (26–48) | 280 | 40 (H) | (17–37) | 0.75 | | 11 | 26 (N) | (10–30) | 53 (L) | (58–82) | 24 (L) | (26–48) | 900 | 28 (N) | (17–37) | 0.8 | | 12 | 8 (L) | (10–30) | 49 (L) | (58–82) | 20 (L) | (26–48) | 310 | 28 (N) | (17–37) | 0.7 |
|
|
